Frances Lynch to Adolescent
This is a "connection" page, showing publications Frances Lynch has written about Adolescent.
Connection Strength
1.372
-
A framework for measuring the cost to families of caring for children's health: the design, methodology, and study population of the r-Kids study. BMC Pediatr. 2023 03 20; 23(1):128.
Score: 0.122
-
Cost-effectiveness of Brief Behavioral Therapy for Pediatric Anxiety and Depression in Primary Care. JAMA Netw Open. 2021 03 01; 4(3):e211778.
Score: 0.106
-
Evidence on the longitudinal construct validity of major generic and utility measures of health-related quality of life in teens with depression. Qual Life Res. 2018 02; 27(2):447-454.
Score: 0.084
-
Measuring Health-related Quality of Life in Teens With and Without Depression. Med Care. 2016 Dec; 54(12):1089-1097.
Score: 0.079
-
A primary care-based, multicomponent lifestyle intervention for overweight adolescent females. Pediatrics. 2012 Mar; 129(3):e611-20.
Score: 0.056
-
Incremental cost-effectiveness of combined therapy vs medication only for youth with selective serotonin reuptake inhibitor-resistant depression: treatment of SSRI-resistant depression in adolescents trial findings. Arch Gen Psychiatry. 2011 Mar; 68(3):253-62.
Score: 0.053
-
Estimating the economic burden of depression in children and adolescents. Am J Prev Med. 2006 Dec; 31(6 Suppl 1):S143-51.
Score: 0.039
-
Cost-effectiveness of an intervention to prevent depression in at-risk teens. Arch Gen Psychiatry. 2005 Nov; 62(11):1241-8.
Score: 0.037
-
Adolescents Who Do Not Endorse Risk via the Patient Health Questionnaire Before Self-Harm or Suicide. JAMA Psychiatry. 2024 Jul 01; 81(7):717-726.
Score: 0.033
-
Clozapine Use Among People With Psychotic Disorders Who Experience Specific Indications for Clozapine. J Clin Psychiatry. 2024 Apr 29; 85(2).
Score: 0.033
-
Impact of treatments for depression on comorbid anxiety, attentional, and behavioral symptoms in adolescents with selective serotonin reuptake inhibitor-resistant depression. J Am Acad Child Adolesc Psychiatry. 2013 May; 52(5):482-92.
Score: 0.031
-
Reduction in avoidance mediates effects of brief behavioral therapy for pediatric anxiety and depression. Behav Res Ther. 2023 05; 164:104290.
Score: 0.030
-
Using natural language processing to identify child maltreatment in health systems. Child Abuse Negl. 2023 Apr; 138:106090.
Score: 0.030
-
Stepped care for suicide prevention in teens and young adults: Design and methods of a randomized controlled trial. Contemp Clin Trials. 2022 12; 123:106959.
Score: 0.030
-
Brief Behavioral Therapy for Anxiety and Depression in Pediatric Primary Care: Breadth of Intervention Impact. J Am Acad Child Adolesc Psychiatry. 2023 02; 62(2):230-243.
Score: 0.029
-
Detecting and distinguishing indicators of risk for suicide using clinical records. Transl Psychiatry. 2022 Jul 13; 12(1):280.
Score: 0.029
-
Rising prevalence of antidepressants among US youths. Pediatrics. 2002 May; 109(5):721-7.
Score: 0.029
-
What health records data are required for accurate prediction of suicidal behavior? J Am Med Inform Assoc. 2019 12 01; 26(12):1458-1465.
Score: 0.024
-
The ReThink study: a 3-arm parallel randomized trial of cognitive bias modification, with and without adherence promotion, for adolescent anxiety disorder: trial design and protocol. BMC Psychiatry. 2019 10 22; 19(1):306.
Score: 0.024
-
Patterns of Health Care Utilization Before First Episode Psychosis in Racial and Ethnic Groups. Ethn Dis. 2019; 29(4):609-616.
Score: 0.024
-
Brief Behavioral Therapy for Pediatric Anxiety and Depression in Primary Care: A Follow-up. J Am Acad Child Adolesc Psychiatry. 2020 07; 59(7):856-867.
Score: 0.024
-
Diagnosed Mental Health Conditions and Risk of Suicide Mortality. Psychiatr Serv. 2019 09 01; 70(9):750-757.
Score: 0.023
-
Care Pathways Before First Diagnosis of a Psychotic Disorder in Adolescents and Young Adults. Am J Psychiatry. 2018 05 01; 175(5):434-442.
Score: 0.021
-
Cost-effectiveness of Cognitive Behavioral Therapy for Depressed Youth Declining Antidepressants. Pediatrics. 2018 02; 141(2).
Score: 0.021
-
Brief Behavioral Therapy for Pediatric Anxiety and Depression in Primary Care: A Randomized Clinical Trial. JAMA Psychiatry. 2017 06 01; 74(6):571-578.
Score: 0.020
-
First Presentation With Psychotic Symptoms in a Population-Based Sample. Psychiatr Serv. 2017 May 01; 68(5):456-461.
Score: 0.020
-
Psychotropic Medication Use among Insured Children with Autism Spectrum Disorder. J Autism Dev Disord. 2017 Jan; 47(1):144-154.
Score: 0.020
-
A Survey of Parents with Children on the Autism Spectrum: Experience with Services and Treatments. Perm J. 2017; 21:16-009.
Score: 0.020
-
Cognitive Behavioral Therapy in Primary Care for Youth Declining Antidepressants: A Randomized Trial. Pediatrics. 2016 May; 137(5).
Score: 0.019
-
Racial-Ethnic Differences in Psychiatric Diagnoses and Treatment Across 11 Health Care Systems in the Mental Health Research Network. Psychiatr Serv. 2016 07 01; 67(7):749-57.
Score: 0.019
-
Health Services Utilization Among Children With and Without Autism Spectrum Disorders. J Autism Dev Disord. 2016 Mar; 46(3):910-20.
Score: 0.019
-
Prevention of Depression in At-Risk Adolescents: Predictors and Moderators of Acute Effects. J Am Acad Child Adolesc Psychiatry. 2016 Mar; 55(3):219-26.
Score: 0.019
-
Effect of a Cognitive-Behavioral Prevention Program on Depression 6 Years After Implementation Among At-Risk Adolescents: A Randomized Clinical Trial. JAMA Psychiatry. 2015 Nov; 72(11):1110-8.
Score: 0.018
-
Validation of Autism Spectrum Disorder Diagnoses in Large Healthcare Systems with Electronic Medical Records. J Autism Dev Disord. 2015 Jul; 45(7):1989-96.
Score: 0.018
-
Methodological considerations in service use assessment for children and youth with mental health conditions; issues for economic evaluation. Adm Policy Ment Health. 2015 May; 42(3):296-308.
Score: 0.018
-
Racial/Ethnic differences in health care visits made before suicide attempt across the United States. Med Care. 2015 May; 53(5):430-5.
Score: 0.018
-
Use of antipsychotic medications in pediatric populations: what do the data say? Curr Psychiatry Rep. 2013 Dec; 15(12):426.
Score: 0.016
-
Prevention of depression in at-risk adolescents: longer-term effects. JAMA Psychiatry. 2013 Nov; 70(11):1161-70.
Score: 0.016
-
Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatment-resistant depression. J Am Acad Child Adolesc Psychiatry. 2012 Apr; 51(4):404-11.
Score: 0.014
-
Services and prevention: pharmacoepidemiology of antidepressant use. Biol Psychiatry. 2001 Jun 15; 49(12):1121-7.
Score: 0.013
-
Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample. J Clin Psychiatry. 2011 Mar; 72(3):388-96.
Score: 0.013
-
Prevention of depression in at-risk adolescents: a randomized controlled trial. JAMA. 2009 Jun 03; 301(21):2215-24.
Score: 0.012
-
Health services use in eating disorders. Psychol Med. 2008 Oct; 38(10):1465-74.
Score: 0.010
-
A randomized effectiveness trial of brief cognitive-behavioral therapy for depressed adolescents receiving antidepressant medication. J Am Acad Child Adolesc Psychiatry. 2005 Sep; 44(9):888-98.
Score: 0.009
-
Patient-based utilities for bipolar disorder-related health states. J Affect Disord. 2005 Aug; 87(2-3):203-10.
Score: 0.009
-
Psychotropic practice patterns for youth: a 10-year perspective. Arch Pediatr Adolesc Med. 2003 Jan; 157(1):17-25.
Score: 0.008
-
Group cognitive-behavioral treatment for depressed adolescent offspring of depressed parents in a health maintenance organization. J Am Acad Child Adolesc Psychiatry. 2002 Mar; 41(3):305-13.
Score: 0.007
-
A randomized trial of a group cognitive intervention for preventing depression in adolescent offspring of depressed parents. Arch Gen Psychiatry. 2001 Dec; 58(12):1127-34.
Score: 0.007